NCT03844295View on ClinicalTrials.gov

Obstructive Sleep Apnea Therapy by Stimulation of the Hypoglossal Nerve

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

March 21, 2019

Primary Completion Date

December 22, 2021

Study Completion Date

October 10, 2023

Conditions
Obstructive Sleep Apnea Syndrome
Interventions
DEVICE

Activated Inspire® Upper Airway Stimulation System

At first, INSPIRE® device will be active a month

DEVICE

Inactivated Inspire® Upper Airway Stimulation System

"After 15 days wash-out INSPIRE® device will be inactivated for a second period of one month."

Trial Locations (1)

38043

UniversityHospitalGrenoble, Grenoble

Sponsors
All Listed Sponsors
collaborator

Inspire Medical Systems, Inc.

INDUSTRY

lead

University Hospital, Grenoble

OTHER

NCT03844295 - Obstructive Sleep Apnea Therapy by Stimulation of the Hypoglossal Nerve | Biotech Hunter | Biotech Hunter